Why do you say CDX-1127 is a "dud?" Do you have supporting evidence?
The CDX-1127 trial is a fairly large trial. There is zero chatter from the science, academic, KOL, and patient communities re: CD27 or, better yet, CDX-1127 itself.
If this was something special, people would be chattering about it. I can't find a single KOL, or doctor interview, or testimonial regarding CD27 or CDX-1127, and this trial has been going on for some time now, and its not a small trial by any means.
IMO, stable disease is probably what will be the outcome here....but that wont stop the bankers from saying PD1 needs CDX-1127.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.